PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Analysis indicates a third H1N1 pandemic wave unlikely in 2010

2010-10-19
(Press-News.org) Analysis of H1N1 antibody levels (seroprotection rates) after the 2009 pandemic suggest that a third wave is unlikely in 2010, although adults over age 50, particularly those with chronic conditions, should be immunized for the fall flu season, states a research paper in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100910.pdf.

The study, by researchers from the BC Centre for Disease Control, University of British Columbia and BC Biomedical Laboratories, compared blood levels of antibodies against the H1N1 influenza before and after the 2009 pandemic. They looked at 1127 people in British Columbia's Lower Mainland aged 9 months to 101 years.

Samples collected before the pandemic indicated that less than 10% of children and adults under age 70 had protective levels of H1N1 antibodies whereas 77% of people over age 80 had protective levels. In follow up after the waves of infection and the fall 2009 immunization campaign, the researchers found a 70% protection rate in people under age 20 but lower seroprotection rates in adults aged 20-49 (44%) and 50-79 years of age (30%). People aged 70-79 years had the lowest rate of antibodies (21%) whereas those over 80 years had higher rates.

"The higher percentage with seroprotection we observed in the young may have resulted from higher pandemic H1N1 infection rates and earlier prioritization of pandemic H1N1 vaccine to young children," writes Dr. Danuta Skowronski, BC Centre for Disease Control and University of British Columbia with coauthors.

They estimate that a community-level protection above 40% would be enough to prevent a large epidemic in a population, especially if school-age children who generally contribute most to the spread of influenza are protected. Given that the overall seroprotection rate is estimated at 46% and 70% in school-age children, "these findings reassure against the likelihood of a substantial third pandemic H1N1 wave during the 2010-11 season, unless there is a significant waning of antibody or change in the virus" the authors state.

"Adults 50-79 years exhibited the lowest seroprotection and also remain at higher risk of severe outcomes if infected," they caution. "Our findings support a shift from the prioritized immunization of the young that occurred in fall 2009 to prioritized immunization of older adults for the coming 2010-11 influenza season to protect against severe outcomes due to both pandemic and seasonal influenza."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Lessons learned from the H1N1 pandemic

2010-10-19
The H1N1 pandemic influenza provided several important lessons that may help in preparing for future influenza outbreaks, write Drs. Donald Low and Allison McGeer in an analysis in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100900.pdf. Although the death rate was lower than initially projected, the years of life lost was significant because "deaths from the 2009 pandemic were skewed toward younger ages than deaths from seasonal influenza," write the authors, both affiliated with Mount Sinai Hospital and the University ...

Tackling cognitive deficits in Alzheimer's disease: 1 'STEP' at a time

2010-10-19
Lowering levels of a key protein involved in regulating learning and memory—STtriatal-Enriched tyrosine Phosphatase (STEP)—reversed cognitive deficits in mice with Alzheimer's disease, Yale School of Medicine researchers report in the October 18 issue of Proceedings of the National Academy of Sciences. "This finding provides a rationale for drug discovery and for developing therapeutic agents that could inhibit STEP proteins and might improve the outlook for Alzheimer's disease patients," said senior author of the study Paul Lombroso, M.D., professor in the Yale Child ...

Beta carotene and retinitis pigmentosa

2010-10-19
CHICAGO—Today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases. The AAO-MEACO meeting–the world's largest, most comprehensive ophthalmic education conference–is in session October 16 through 19 at McCormick Place, Chicago. 9-cis Beta-Carotene Mat Boost Vision in Some Patients with Incurable Retinal Disease Retinitis pigmentosa (RP) is a cluster of hereditary disorders ...

New evidence of the power of open access

2010-10-19
New findings settle one of the arguments about Open Access (OA) research publications: Are they more likely to be cited because they were made OA, or were they made OA because they were more likely to be cited? The study, which will be published in PLoS ONE on the first day of Open Access Week (18 October), was carried out by a bi-national team of researchers from the University of Southampton's School of Electronics and Computer Science (ECS) in the UK and l'Université du Québec à Montréal in Canada. The results show that the OA citation impact advantage is just ...

Surgical complications drop at hospitals that share patient safety data

2010-10-19
ANN ARBOR, Mich. – Michigan hospitals reduced surgical complications by nearly 10 percent at a time when the rest of the nation saw no change in complication rates, according to a new study out next week in the Archives of Surgery. Complications dropped at hospitals participating in what's called the Michigan Surgical Quality Collaborative, a group of 16 hospitals led by the University of Michigan Health System that agreed to pool data and share information about what keeps patients safe. The fewer patients suffering ventilator associated pneumonias alone, among the ...

News and insights in gastroenterology presented at the ACG's 75th Annual Meeting

2010-10-19
Bethesda, Maryland (October 14, 2010) – Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management. Innovative technologies for the diagnosis and treatment of digestive diseases; insights into digestive health conditions, their causes and how they impact ...

Allergy drug found to clear condition but not symptoms of throat disease

2010-10-19
ROCHESTER, Minn. -- A group of Mayo Clinic (http://www.mayoclinic.org/about/) researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis (http://www.mayoclinic.org/eosinophilic-esophagitis/). Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology ...

The protein NOS2 isn't good for ER-negative breast cancer patients

2010-10-19
Breast cancers can be divided into different subtypes based on several criteria, including whether or not they express the protein to which the female hormone estrogen binds; that is, the estrogen receptor (ER). Patients with ER-negative breast tumors have a worse outlook than those with ER-positive breast tumors. However, even among ER-negative breast tumors, those characterized as basal-like are the most aggressive and difficult to treat. New therapeutic targets for this subtype of breast cancer are urgently needed. Now, a team of researchers, led by Stefan Ambs, at the ...

JCI online early table of contents: Oct. 18, 2010

2010-10-19
EDITOR'S PICK: The protein NOS2 isn't good for ER-negative breast cancer patients Breast cancers can be divided into different subtypes based on several criteria, including whether or not they express the protein to which the female hormone estrogen binds; that is, the estrogen receptor (ER). Patients with ER-negative breast tumors have a worse outlook than those with ER-positive breast tumors. However, even among ER-negative breast tumors, those characterized as basal-like are the most aggressive and difficult to treat. New therapeutic targets for this subtype of breast ...

Medicare hospital comparison website may not help patients locate best places for high-risk surgery

2010-10-19
Information available on a government Web site designed to help patients choose high-quality hospitals does not appear to help Medicare beneficiaries identify facilities with better outcomes for high-risk surgeries, according to a report in the October issue of Archives of Surgery, one of the JAMA/Archives journals. In an effort to reduce variations in surgical quality, the Centers for Medicare and Medicaid Services (CMS) now requires hospitals to report data from the national Surgical Care Improvement Project involving measures taken to prevent infection and blood clots, ...

LAST 30 PRESS RELEASES:

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

More scrutiny of domestic fishing fleets at ports could help deter illegal fishing

Scientists transform plastic waste into efficient CO2 capture materials

Discovery of North America’s role in Asia’s monsoons offers new insights into climate change

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

Researchers discover massive geo-hydrogen source to the west of the Mussau Trench

Even untouched ecosystems are losing insects at alarming rates, new study finds

Adaptive visible-infrared camouflage with wide-range radiation control for extreme ambient temperatures

MD Anderson research highlights for September 5, 2025

Physicists create a new kind of time crystal that humans can actually see

Reminder: Final media invitation for EPSC-DPS2025 and details of media briefings on RAMSES and Juno missions

Understanding orderly and disorderly behavior in 2D nanomaterials could enable bespoke design, tailored by AI

JAMA Network launches JAMA+ Women's Health

Surface plasmon driven atomic migration mediated by molecular monolayer

ERC Starting Grant for five University of Groningen scientists

AI turns printer into a partner in tissue engineering

What climate change means for the Mediterranean Sea

[Press-News.org] Analysis indicates a third H1N1 pandemic wave unlikely in 2010